Literature DB >> 25492025

One device, one equation: the simplest way to objectively evaluate psoriasis severity.

Jae Woo Choi1, Bo Ri Kim, Chong Won Choi, Sang Woong Youn.   

Abstract

The erythema, scale and thickness of psoriasis lesions could be converted to bioengineering parameters. An objective psoriasis severity assessment is advantageous in terms of accuracy and reproducibility over conventional severity assessment. We aimed to formulate an objective psoriasis severity index with a single bioengineering device that can possibly substitute the conventional subjective Psoriasis Severity Index. A linear regression analysis was performed to derive the formula with the subjective Psoriasis Severity Index as the dependent variable and various bioengineering parameters determined from 157 psoriasis lesions as independent variables. The construct validity of the objective Psoriasis Severity Index was evaluated with an additional 30 psoriasis lesions through a Pearson correlation analysis. The formula is composed of hue and brightness, which are sufficiently obtainable with a Colorimeter alone. A very strong positive correlation was found between the objective and subjective psoriasis severity indexes. The objective Psoriasis Severity Index is a novel, practical and valid assessment method that can substitute the conventional one. Combined with subjective area assessment, it could further replace the Psoriasis Area and Severity Index which is currently most popular.
© 2014 Japanese Dermatological Association.

Entities:  

Keywords:  Colorimeter; Psoriasis Severity Index; bioengineering; objective; psoriasis

Mesh:

Year:  2014        PMID: 25492025     DOI: 10.1111/1346-8138.12727

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  1 in total

1.  Reduction of Inter-Rater and Intra-Rater Variability in Psoriasis Area and Severity Index Assessment by Photographic Training.

Authors:  Sang Woong Youn; Chong Won Choi; Bo Ri Kim; Je Byeong Chae
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.